Present On Admission Exempt Codes
ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2027 CMS POA exempt list.
Advertisements
Codes on this list
38,399 codes, page 16 of 384.
- Q91.2Trisomy 18, translocation
- Q91.3Trisomy 18, unspecified
- Q91.4Trisomy 13, nonmosaicism (meiotic nondisjunction)
- Q91.5Trisomy 13, mosaicism (mitotic nondisjunction)
- Q91.6Trisomy 13, translocation
- Q91.7Trisomy 13, unspecified
- Q92.0Whole chromosome trisomy, nonmosaicism (meiotic nondisjunction)
- Q92.1Whole chromosome trisomy, mosaicism (mitotic nondisjunction)
- Q92.2Partial trisomy
- Q92.5Duplications with other complex rearrangements
- Q92.61Marker chromosomes in normal individual
- Q92.62Marker chromosomes in abnormal individual
- Q92.7Triploidy and polyploidy
- Q92.8Other specified trisomies and partial trisomies of autosomes
- Q92.9Trisomy and partial trisomy of autosomes, unspecified
- Q93.0Whole chromosome monosomy, nonmosaicism (meiotic nondisjunction)
- Q93.1Whole chromosome monosomy, mosaicism (mitotic nondisjunction)
- Q93.2Chromosome replaced with ring, dicentric or isochromosome
- Q93.3Deletion of short arm of chromosome 4
- Q93.4Deletion of short arm of chromosome 5
- Q93.51Angelman syndrome
- Q93.52Phelan-McDermid syndrome
- Q93.59Other deletions of part of a chromosome
- Q93.7Deletions with other complex rearrangements
- Q93.81Velo-cardio-facial syndrome
- Q93.82Williams syndrome
- Q93.88Other microdeletions
- Q93.89Other deletions from the autosomes
- Q93.9Deletion from autosomes, unspecified
- Q95.0Balanced translocation and insertion in normal individual
- Q95.1Chromosome inversion in normal individual
- Q95.2Balanced autosomal rearrangement in abnormal individual
- Q95.3Balanced sex/autosomal rearrangement in abnormal individual
- Q95.5Individual with autosomal fragile site
- Q95.8Other balanced rearrangements and structural markers
- Q95.9Balanced rearrangement and structural marker, unspecified
- Q96.0Karyotype 45, X
- Q96.1Karyotype 46, X iso (Xq)
- Q96.2Karyotype 46, X with abnormal sex chromosome, except iso (Xq)
- Q96.3Mosaicism, 45, X/46, XX or XY
- Q96.4Mosaicism, 45, X/other cell line(s) with abnormal sex chromosome
- Q96.8Other variants of Turner's syndrome
- Q96.9Turner's syndrome, unspecified
- Q97.0Karyotype 47, XXX
- Q97.1Female with more than three X chromosomes
- Q97.2Mosaicism, lines with various numbers of X chromosomes
- Q97.3Female with 46, XY karyotype
- Q97.8Other specified sex chromosome abnormalities, female phenotype
- Q97.9Sex chromosome abnormality, female phenotype, unspecified
- Q98.0Klinefelter syndrome karyotype 47, XXY
- Q98.1Klinefelter syndrome, male with more than two X chromosomes
- Q98.3Other male with 46, XX karyotype
- Q98.4Klinefelter syndrome, unspecified
- Q98.5Karyotype 47, XYY
- Q98.6Male with structurally abnormal sex chromosome
- Q98.7Male with sex chromosome mosaicism
- Q98.8Other specified sex chromosome abnormalities, male phenotype
- Q98.9Sex chromosome abnormality, male phenotype, unspecified
- Q99.0Chimera 46, XX/46, XY
- Q99.146, XX true hermaphrodite
- Q99.2Fragile X chromosome
- Q99.811Usher syndrome, type 1
- Q99.812Usher syndrome, type 2
- Q99.813Usher syndrome, type 3
- Q99.818Other Usher syndrome
- Q99.819Usher syndrome, unspecified
- Q99.89Other specified chromosome abnormalities
- Q99.9Chromosomal abnormality, unspecified
- QA0.0101SCN2A-related neurodevelopmental disorder
- QA0.0102CACNA1A-related neurodevelopmental disorder
- QA0.0109Neurodevelopmental disorder related to pathogenic variant in other ion channel gene
- QA0.011Neurodevelopmental disorders, related to pathogenic variants in glutamate receptor genes
- QA0.012Neurodevelopmental disorders, related to pathogenic variants in other receptor genes
- QA0.0131SLC6A1-related disorder
- QA0.0139Neurodevelopmental disorder, related to pathogenic variant in other transporter or solute carrier gene
- QA0.0141Syntaxin-binding protein 1-related disorder
- QA0.0142DLG4-related synaptopathy
- QA0.0149Neurodevelopmental disorder, related to pathogenic variant in other synapse related gene
- QA0.0151FOXG1 syndrome
- QA0.0159Neurodevelopmental disorder, related to other genes associated with transcription and gene expression
- QA0.8Other neurodevelopmental disorders related to pathogenic variants in other specific genes
- QA1.71Lynch syndrome
- QA1.790Familial cancer syndrome with pathogenic BRCA1 mutation
- QA1.791Familial cancer syndrome with pathogenic BRCA2 mutation
- QA1.792Li Fraumeni syndrome
- QA1.798Other inherited neoplasm predisposition syndrome of multiple systems
- S00.00XDUnspecified superficial injury of scalp, subsequent encounter
- S00.00XSUnspecified superficial injury of scalp, sequela
- S00.01XDAbrasion of scalp, subsequent encounter
- S00.01XSAbrasion of scalp, sequela
- S00.02XDBlister (nonthermal) of scalp, subsequent encounter
- S00.02XSBlister (nonthermal) of scalp, sequela
- S00.03XDContusion of scalp, subsequent encounter
- S00.03XSContusion of scalp, sequela
- S00.04XDExternal constriction of part of scalp, subsequent encounter
- S00.04XSExternal constriction of part of scalp, sequela
- S00.05XDSuperficial foreign body of scalp, subsequent encounter
- S00.05XSSuperficial foreign body of scalp, sequela
- S00.06XDInsect bite (nonvenomous) of scalp, subsequent encounter
- S00.06XSInsect bite (nonvenomous) of scalp, sequela